2023
DOI: 10.22541/au.169028549.98984454/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Rare Association of Plasmodium Vivax Malaria with Pulmonary Thromboembolism: A Case Report

Gashaw Solela,
Merga Daba,
Zerubabel Geahun
et al.

Abstract: Introduction:The hypercoagulable complications of malaria typically manifest in the microvasculature. However, there are several cases of intracranial venous thrombosis caused by Plasmodium falciparum and Plasmodium vivax malaria and there was one case report of pulmonary thromboembolism due to Plasmodium falciparum. To the best of our knowledge, there have not been case reports of plasmodium vivax associated with pulmonary thromboembolism.Case Presentation: A 30-year-old Ethiopian male patient presented with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Two cases were described in the literature, one of massive venous thromboembolism due to plasmodium falciparum infection associated with disseminated intravascular coagulation, in which the patient had a poor outcome, the second pulmonary thromboembolism due to plasmodium vivax attributed to hypercoagulable changes in malaria, with favorable evolution of the patient [7,8]. In our case, we believe that plasmodium falciparum infection was the basis for the activation of the coagulation cascade, resulting in high-risk PTE (presence of hemodynamic instability), without evidence of DIC in a patient without identified risk factors for hypercoagulability [9,10].…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Two cases were described in the literature, one of massive venous thromboembolism due to plasmodium falciparum infection associated with disseminated intravascular coagulation, in which the patient had a poor outcome, the second pulmonary thromboembolism due to plasmodium vivax attributed to hypercoagulable changes in malaria, with favorable evolution of the patient [7,8]. In our case, we believe that plasmodium falciparum infection was the basis for the activation of the coagulation cascade, resulting in high-risk PTE (presence of hemodynamic instability), without evidence of DIC in a patient without identified risk factors for hypercoagulability [9,10].…”
Section: Discussionmentioning
confidence: 96%
“…There are five species that cause disease in humans, namely plasmodium falciparum, plasmodium vivax, plasmodium ovale, plasmodium malariae and plasmodium knowlesi [7]. Severe malaria is usually caused by plasmodium falciparum, however, severe malaria and even deaths can occur in patients infected with plasmodium vivax [3,10]. Severe manifestations described include changes in consciousness, generalized convulsions, metabolic acidosis, liver dysfunction, hypoglycemia, renal dysfunction, respiratory distress, disseminated intravascular coagulation, severe anemia, shock and death [8].…”
Section: Discussionmentioning
confidence: 99%